MCI Clinical Trials

101 recruitingLast updated: June 6, 2026

There are 101 actively recruiting mci clinical trials across 31 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1, Phase 4. Top locations include Toronto, Ontario, Canada, Phoenix, Arizona, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


MCI Trials at a Glance

101 actively recruiting trials for mci are listed on ClinicalTrialsFinder across 6 cities in 31 countries. The largest study group is Not Applicable with 54 trials, with the heaviest enrollment activity in Toronto, Phoenix, and Boston. Lead sponsors running mci studies include St. Joseph's Hospital and Medical Center, Phoenix, University of California, San Francisco, and Centre for Addiction and Mental Health.

Treatments under study

About MCI Clinical Trials

Looking for clinical trials for MCI? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new MCI trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about MCI clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 101 trials

Recruiting

Dementia With Lewy Bodies: Clinical Symptoms, Biomarkers and Progression

Mild Cognitive Impairment (MCI)Other DementiasCognitively Unimpaired+1 more
Karolinska Institutet600 enrolled1 locationNCT07629349
Recruiting

Crownlands Observing Progression With Neurons Study

Mild Cognitive Impairment (MCI)Alzheimer s Disease
Crownlands160 enrolled1 locationNCT07611396
Recruiting
Phase 1

Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients

Mild Cognitive Impairment (MCI)
Pravat Mandal9 enrolled1 locationNCT07583251
Recruiting
Not Applicable

Telehealth-Adapted Compensatory Training and Intervention for Cognition

Mild Cognitive Impairment (MCI)Mild Cognitive ImpairmentMCI
University of Florida100 enrolled1 locationNCT07366346
Recruiting
Phase 2

Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.

Mild Cognitive ImpairmentEarly Alzheimer's DiseaseAD-MCI
Bernard (Barry) Baumel10 enrolled1 locationNCT07512362
Recruiting
Not Applicable

Brain Stimulation and Cognitive Training for MCI

Mild Neurocognitive DisorderCognitive DysfunctionMild Cognitive Impairment (MCI)+2 more
Medical University of South Carolina50 enrolled1 locationNCT07526740
Recruiting
Phase 2

Biomarker-based Trial of NPC-1 for Alzheimer's Pathology

Alzheimer DiseaseMild Cognitive Impairment (MCI)Subjective Cognitive Decline (SCD)
Massachusetts General Hospital40 enrolled1 locationNCT07236190
Recruiting
Phase 2

Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease

Alzheimer s DiseaseMild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Weill Medical College of Cornell University20 enrolled1 locationNCT07553338
Recruiting
Phase 4

Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs

Alzheimer Dementia (AD)Alzheimer s DiseaseMCI-AD, Early Stage Alzheimer's Disease
First Affiliated Hospital of Wenzhou Medical University200 enrolled1 locationNCT07604896
Recruiting
Not Applicable

Mindfulness With Dual-Task Training in Post-Stroke Mild Cognitive Impairment

StrokeMild Cognitive Impairment (MCI)
Nanjing Mingzhou Rehabilitation Hospital60 enrolled1 locationNCT07603102
Recruiting
Not Applicable

Creatine and Resistance Training in Older Adults With Mild Cognitive Impairment

ExerciseMild Cognitive Impairment (MCI)Creatine
Western University, Canada200 enrolled1 locationNCT06948149
Recruiting
Not Applicable

Computerized Cognitive Training in Healthy Older Adults and Mild Cognitive Impairment

Mild Cognitive Impairment (MCI)Healthy Aging
Universidad Antonio de Nebrija156 enrolled2 locationsNCT07598409
Recruiting
Not Applicable

Instant Message-delivered Personalised Acceptance and Commitment Therapy (IMPACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment

Mild Cognitive Impairment (MCI)
The University of Hong Kong160 enrolled1 locationNCT07420426
Recruiting
Phase 1

A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic Efficacy

MCIAD - Alzheimer's Disease
Eli Radiopharma18 enrolled1 locationNCT07580703
Recruiting
Not Applicable

e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most

DementiaMild Cognitive Impairment (MCI)Potentially Inappropriate Medication Use
Johns Hopkins University100 enrolled1 locationNCT07454824
Recruiting
Not Applicable

δ in Dementia Clinical Trials

DementiaCognitive DeclineAlzheimer's Disease(AD)+1 more
The University of Texas Health Science Center at San Antonio200 enrolled1 locationNCT05592678
Recruiting

Community-based Screening for Alzheimer's Disease

Cognitive ImpairmentMild Cognitive Impairment (MCI)Alzheimer's Disease(AD)
Kuang XiaoJun3,000 enrolled4 locationsNCT07570719
Recruiting
Not Applicable

Personalized Digital Training for COGnitive FITness in Mild Cognitive Impairment

Mild Cognitive Impairment (MCI)Subjective Cognitive Decline (SCD)
Giovanna Zamboni100 enrolled2 locationsNCT07286448
Recruiting
Not Applicable

Non-invasive Stimulation of Deep Brain Structures to Modulate Working Memory

Mild Cognitive Impairment (MCI)Older Adults (60 - 85 Years Old)
Masaryk University70 enrolled1 locationNCT07560904
Recruiting

Genetic Studies of Early-onset Dementia

Mild Cognitive Impairment (MCI)Alzheimer Dementia (AD)Memory Loss+1 more
Columbia University1,000 enrolled1 locationNCT04906863